KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Operating Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 2,500.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -91.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 395.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -4,555.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -53.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 1,031.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -9,003.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -338.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -338.00
Dec 31, 2025 -1,458.00
Sep 30, 2025 -134.00
Jun 30, 2025 -662.00
Mar 31, 2025 618.00
Dec 31, 2024 -3,342.00
Sep 30, 2024 -962.00
Jun 30, 2024 -855.00
Mar 31, 2024 -11,896.00
Dec 31, 2023 11,139.00
Sep 30, 2023 -104.00
Jun 30, 2023 152.00
Mar 31, 2023 3,859.00
Dec 31, 2022 2,655.00
Sep 30, 2022 606.00
Jun 30, 2022 -329.00
Mar 31, 2022 -935.00
Dec 31, 2021 -240.00
Sep 30, 2021 -1,027.00
Jun 30, 2021 1,174.00
Mar 31, 2021 -656.00
Dec 31, 2020 -10,415.00
Sep 30, 2020 521.00
Jun 30, 2020 -526.00
Mar 31, 2020 -5,079.00
Dec 31, 2019 -2,689.00
Sep 30, 2019 -1,250.00
Jun 30, 2019 -1,152.00
Mar 31, 2019 -1,111.00
Dec 31, 2018 3,001.00
Sep 30, 2018 1,182.00
Jun 30, 2018 366.00
Mar 31, 2018 -1,112.00
Dec 31, 2017 752.00
Sep 30, 2017 -756.00
Jun 30, 2017 864.00
Mar 31, 2017 1,355.00
Dec 31, 2016 299.00
Sep 30, 2016 1,394.00
Jun 30, 2016 2,268.00
Mar 31, 2016 2,389.00
Dec 31, 2015 -1,836.00
Sep 30, 2015 5,741.00
Jun 30, 2015 -1,890.00
Mar 31, 2015 108.00
Dec 31, 2014 -2,826.00
Sep 30, 2014 -789.00
Jun 30, 2014 -1,965.00
Mar 31, 2014 -802.00
Dec 31, 2013 -908.00
Sep 30, 2013 -1,574.00
Jun 30, 2013 -2,089.00
Mar 31, 2013 -1,319.00
Dec 31, 2012 -1,116.00
Sep 30, 2012 -6,530.00
Jun 30, 2012 -1,055.00
Mar 31, 2012 1,309.00